Intravascular Imaging Incorporated ("I3") Announces Launch Of Its 3-French Nirf-Ivus Imaging Catheter Intended For Human Coronary Imaging, With Favorable Tests In Ex-Vivo Human Coronaries, And Launch Of Series A Financing
Intravascular Imaging Incorporated ("I3") Announces Launch Of Its 3-French Nirf-Ivus Imaging Catheter Intended For Human Coronary Imaging, With Favorable Tests In Ex-Vivo Human Coronaries, And Launch Of Series A Financing
07/18/22, 1:45 PM
Location
bostonIndustry
science and engineering
other
Round Type
series a
I3 today announced the launch of its proprietary 3-French NIRF-IVUS Catheter designed in collaboration with the Massachusetts General Hospital. The device was tested in ex-vivo human coronary arteries and in vivo in preclinical studies, using its proprietary NIRF-IVUS intravascular imaging system. I3's imaging system combines intravascular ultrasound ("IVUS"), the dominant imaging approach used for coronary stent optimization during percutaneous coronary intervention (PCI), with near-infrared fluorescence imaging ("NIRF"). Combined into a single catheter, NIRF-IVUS enables visualization of the molecular and cellular details that underline pathophysiologic progression of coronary lesions, arterial dissections, coronary transplant vasculopathy, and fibrin production in unhealed stents.
Company Info
Location
boston, massachusetts, united states
Additional Info
The company, incorporated in 2018, has designed and developed a 3.0 French intracoronary NIRF-IVUS imaging catheter and imaging system, capable of molecular and pathophysiologic imaging, which will be marketed as an upgrade to the large and fast-growing world-wide installed base of IVUS systems used for stent placement procedures.